دورية أكاديمية

Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

التفاصيل البيبلوغرافية
العنوان: Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)
المؤلفون: McInnes, Iain B *, Asahina, Akihiko, Coates, Laura C, Landewé, Robert, Merola, Joseph F, Ritchlin, Christopher T, Tanaka, Yoshiya, Gossec, Laure, Gottlieb, Alice B, Warren, Richard B, Ink, Barbara, Assudani, Deepak, Bajracharya, Rajan, Shende, Vishvesh, Coarse, Jason, Mease, Philip J
المصدر: In The Lancet 7-13 January 2023 401(10370):25-37
قاعدة البيانات: ScienceDirect
الوصف
تدمد:01406736
DOI:10.1016/S0140-6736(22)02302-9